Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthofix Medical (OFIX) Income from Continuing Operations (2016 - 2026)

Orthofix Medical has reported Income from Continuing Operations over the past 17 years, most recently at 20908000.0 for Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations rose 60.62% year-over-year to 20908000.0, compared with a TTM value of 33267000.0 through Mar 2026, up 123.25%, and an annual FY2025 reading of 1081000.0, up 100.86% over the prior year.
  • Income from Continuing Operations came in at 20908000.0 for Q1 2026, down from 91051000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 132620000.0 in Q4 2023 to a low of 60938000.0 in Q1 2023.
  • Median Income from Continuing Operations over the past 5 years was 22795000.0 (2025), compared with a mean of 9539647.06.
  • The largest YoY upside for Income from Continuing Operations was 1977.94% in 2023 against a maximum downside of 1684.01% in 2023.
  • Over 5 years, Income from Continuing Operations stood at 7062000.0 in 2022, then skyrocketed by 1977.94% to 132620000.0 in 2023, then crashed by 121.98% to 29146000.0 in 2024, then skyrocketed by 412.4% to 91051000.0 in 2025, then plummeted by 122.96% to 20908000.0 in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Income from Continuing Operations are 20908000.0 (Q1 2026), 91051000.0 (Q4 2025), and 22795000.0 (Q3 2025).